This document discusses myopathies, which are muscle diseases. It classifies myopathies into hereditary and acquired categories. Hereditary myopathies include muscular dystrophies such as Duchenne's muscular dystrophy. Acquired myopathies can be inflammatory, endocrine, or drug-induced. Duchenne's muscular dystrophy is an X-linked recessive disorder affecting 1 in 3,500 male births. It is caused by a defect in the dystrophin gene and leads to progressive muscle weakness and atrophy. Symptoms begin in early childhood and worsen over time, ultimately resulting in death.
MYOPATHIES A SPECIAL AND SEPERATE ENTITY WITH SPECIFIC FEATURES IN EACH DISORDER MAKING US EASY FOR DIAGNOSIS,CONFIRMATION BY MUSCLE BIOPSY.THE SEMINAR WAS PRSENTED ON 06/07/2011...AT 09.00AM
HAVE A LOOK ..AND COMMENT..WITHOUT BIAS..
this presentation briefly discus about muscle and its related disorder. some myopathies which are common are cover here in an approach to provide basis of the same disease and treatment. this ppt is basically from chapter 32 zakazewski.
MYOPATHIES A SPECIAL AND SEPERATE ENTITY WITH SPECIFIC FEATURES IN EACH DISORDER MAKING US EASY FOR DIAGNOSIS,CONFIRMATION BY MUSCLE BIOPSY.THE SEMINAR WAS PRSENTED ON 06/07/2011...AT 09.00AM
HAVE A LOOK ..AND COMMENT..WITHOUT BIAS..
this presentation briefly discus about muscle and its related disorder. some myopathies which are common are cover here in an approach to provide basis of the same disease and treatment. this ppt is basically from chapter 32 zakazewski.
CP is the most common motor disability in childhood. Cerebral means having to do with the brain. Palsy means weakness or problems with using the muscles. CP is caused by abnormal brain development or damage to the developing brain that affects a person's ability to control his or her muscles.
FA is a very rare, genetic, recessive disease, affecting 1/50,000 people.
Originates from mutations in the “coding” of the mitochondria.
Discovered by Nicholaus Friedreich in the early 1860’s.
Both parents must have the dominant trait for a 25% chance of an offspring possessing the disease.
Not necessarily a disease that kills you, but eventually a wheelchair and regular assistance will be required.
Onset before age 20-25 year.
CP is the most common motor disability in childhood. Cerebral means having to do with the brain. Palsy means weakness or problems with using the muscles. CP is caused by abnormal brain development or damage to the developing brain that affects a person's ability to control his or her muscles.
FA is a very rare, genetic, recessive disease, affecting 1/50,000 people.
Originates from mutations in the “coding” of the mitochondria.
Discovered by Nicholaus Friedreich in the early 1860’s.
Both parents must have the dominant trait for a 25% chance of an offspring possessing the disease.
Not necessarily a disease that kills you, but eventually a wheelchair and regular assistance will be required.
Onset before age 20-25 year.
A brief coverage of all IIM, including major junk of #Polymyositis, #Dermatomyositis #InclusionBodyMyositis and other IIM's.
Includes classification, characteristic features of all and specific features of each of them with diagnosing and approach to management.
NB: This presentation is equipped with animations, which might not work on slideshare
This presentation will give a brief idea on proximal myopathy, causes, clinical presentation, history and physical examination, investigations to diagnose the disease easily.
It will be more helpful to medical students.
This powerpoint i talked about the types classification of the Muscular disorder , followed by Duchenne Muscular dystrophy Clinical features, pathophysiology, Diagnosis , followed by the latest treatment available for its treatment.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Myopathy for medical students
1. MYOPATHYMYOPATHY
Prof. AshrAf AbdouProf. AshrAf Abdou
Neuropsychiatry deptNeuropsychiatry dept
Faculty of medicineFaculty of medicine
Alexandria univAlexandria univ
3. When you think aboutWhen you think about
muscle disease?muscle disease?
Weakness:Weakness:
– Child: delayed sitting, standing, walkingChild: delayed sitting, standing, walking
– Adult:Adult:
going upstairs – walking long distance – walking –going upstairs – walking long distance – walking –
standingstanding
Difficulty in carrying heavy objects – difficulty inDifficulty in carrying heavy objects – difficulty in
combing haircombing hair
No sensory complaintNo sensory complaint
No sphincters control problemNo sphincters control problem
MayalgiaMayalgia
4. When you think aboutWhen you think about
muscle disease?muscle disease?
Clincal examinationClincal examination
– Weakness: Bilateral – symmetricalWeakness: Bilateral – symmetrical
– proximal– proximal
– Muscle atrophyMuscle atrophy
5. When you thinkWhen you think
about muscleabout muscle
disease?disease?
Clincal examinationClincal examination
– No sensory abnormalitiesNo sensory abnormalities
– Skeletal deformitiesSkeletal deformities
9. Muscular DystrophyMuscular Dystrophy
Group of inherited diseases
Leads to chronic progressive
muscle atrophy
Usually appears in early
childhood
Most types result in total
disability and early death
11. Prevalence of DMDPrevalence of DMD
Affects 1 in 3500Affects 1 in 3500
newborn malesnewborn males
1/3 of these with1/3 of these with
previous familyprevious family
historyhistory
2/3 sporadic2/3 sporadic
14. Muscles that are affectedMuscles that are affected
In the early stages,In the early stages,
Duchenne MD affectDuchenne MD affect
the pectoral musclesthe pectoral muscles
, the trunk,, the trunk,
hamsterings, calfhamsterings, calf
musclemuscle
These weaknessesThese weaknesses
lead to difficulty inlead to difficulty in
rising, climbingrising, climbing
stairs andstairs and
maintaining balance.maintaining balance.
15. Symptoms of DMDSymptoms of DMD
Delayed developmentalDelayed developmental
milestonesmilestones
Loss of motor skillsLoss of motor skills
Characteristic gaitCharacteristic gait
Calf hypertrophyCalf hypertrophy
Clumsiness/frequent fallsClumsiness/frequent falls
19. Prenatal diagnosisPrenatal diagnosis
This is achieved by studying the foetus’sThis is achieved by studying the foetus’s
own DNA on a chorion villus biopsy.own DNA on a chorion villus biopsy.
The test is performed on a tiny piece of theThe test is performed on a tiny piece of the
developing placenta usually at the 11developing placenta usually at the 11thth
–12–12thth
week of pregnancy.week of pregnancy.
Duchenne Becker Muscular dystrophy affects about one in every 3500 to 5000 newborn males.
One third of these boys have a previous relative with DMD. Two thirds of the cases are sporadic. There are two groups that make up the sporadic cases. In 1/3 of cases (or ½ of the sporadic cases), there was a genetic mutation in the mother’s egg or a genetic mutation early in embryo development that led to the condition. In the other 1/3 of cases (other ½ of sporadic cases), the mother is a carrier, but she is carrying a new mutation that occurred in either her mother’s egg, her father’s sperm, or early in her development. This explains the cases where a boy is born with Duchenne Becker muscular dystrophy into a family with absolutely no history of the condition. (1)
Graphic citation:
Microsoft Office Clipart 2002. [cited 23 June, 2005].
Hilda, this is from Katherines presentation. She had a similar slide and I took notes as she talked. I think that someone even asked about sporadic….
Symptoms usually begin to occur around 2-3 years of age. The boys may show delayed developmental milestones. For example, they are not sitting up or crawling when other boys their age begin.
Loss of motor skills may be apparent. Once they begin to walk, it may become more difficult as time goes on.
Boys tend to have a characteristic gait shown by walking on their toes. The Achilles' tendon becomes tight because of the muscle contraction in the calf and it is uncomfortable to bring the heel down. The calves will appear larger (hypertrophy). This is due to the loss of muscle being replaced with fat and connective tissue.
Finally, as the muscles weaken, the boys may appear clumsy and fall frequently. (1)
As the boy gets older, muscle weakness will become apparent. The calf muscles are the first to weaken, so walking up stairs or hills becomes difficult.
Gower’s sign is used in diagnosing the condition. This symptom shows the boy using his arms to get up from a sitting position because the leg muscles are too weak to allow for the task. (Click on the link and scroll down to Figure 2 to see Gower’s sign).
Finally, walking and running will become difficult. (1)
Link to Gower’s sign via the internet:
Kalra, V. Childhood Muscular Dystrophies [online]. 2005. [cited 2005 June 26]. Available from URL: http://www.indegene.com/Neu/FeatArt/indNeuFeatArt4.html?type=Neu